Edaravone
Edaravone is a novel free radical scavenger, which was first marketed in Japan in April 2001 and is mainly used in the treatment of ischemic stroke.
| Supplier | CD Formulation |
|---|---|
| Product # | PAP-0070 |
| Pricing | , Inquire for price |
| Solubility | 3.30g/l |
| product1 | Cardiovascular Series |
| Storage | 2-8°C |
| Molecular Formula | C10H10N2O |
| Applications | Edala is considered a brain protectant (free radical scavenger). It is mainly used to treat the acute attack of cerebral infarction and improve the neurological symptoms, activities of daily living and functional disorders caused by acute cerebral infarction. |
| Boiling Point | 287 °C265 mm Hg(lit.) |
| Melting Point | 126-128 °C(lit.) |
| Density | 1,12 g/cm3 |
| CAS Number | 89-25-8 |
| Category | Cardiovascular |
| Appearance | Crystalline Powder |
| Color | Yellow to beige |
| Physical State | Crystalline Powder |